Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.
Clarity Pharmaceuticals has raised $132.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.
Clarity Pharmaceuticals's investors include Cicada Innovations, University of Melbourne, Sydney Angels, Australian Nuclear Science and Technology Organization, ATP Innovations.
Clarity Pharmaceuticals is headquartered in Sydney, Australia.
Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.
Clarity Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clarity Pharmaceuticals — Funding & Investors." VCBacked, July 28, 2025, https://www.vcbacked.co/company/clarity-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2025). Clarity Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/clarity-pharmaceuticals
{{cite web |title=Clarity Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/clarity-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated